Trump Administration to Announce Medicare, Medicaid Will Cover Eventual COVID-19 Vaccine According to Report

The Trump administration is expected to announce that the eventual coronavirus vaccine will be covered by Medicare and Medicaid, Politico reported late Monday.

The administration is expected to change a rule that previously prevented Medicare and Medicaid from covering vaccines that received emergency use authorization from the FDA. The official announcement is expected from the Center for Medicare and Medicaid Services (CMS) Tuesday or Wednesday, according to Politico.

Read More

AstraZeneca, Johnson and Johnson Resuming U.S. Tests of COVID-19 Vaccines

Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.

Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.

Read More

CVS to Hire 15,000 Employees in Preparation for Flu Season, COVID-19 Vaccine Rollout

CVS Health announced that it would bring on approximately 15,000 additional workers in preparation for the upcoming flu season and an expected rise in coronavirus cases before the distribution of an eventual vaccine.

The hirings will take place before the year’s end, the company said Monday in a statement. Though most of the positions are temporary, many could transition into full-time positions, CVS said.

Read More

NIH: Halted Vaccine Study Shows ‘No Compromises’ on Safety

The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.

Read More